Stock Market Today: Stocks Waver as Revised Jobs Data Sparks Rate-Cut Speculation
CrowdStrike Sees AI as Both Threat and Opportunity in Cybersecurity Market
CrowdStrike (NASDAQ: CRWD), a leading cybersecurity firm, is positioning itself at the forefront of the industry as artificial intelligence reshapes both threats and defenses.
QuantumScape Surges 20% as Solid-State Battery Demo Ignites Investor Optimism
EMX Royalty On The Brink Of A Buyout By Elemental — Is This The Start Of Royalty Market Consolidation?
Business & Market Movers
Phreesia’s $160 Million AccessOne Acquisition: Will This Deal Redefine Healthcare Payments?
·Sep 09, 2025
EOS Energy Just Hit An All-Time High — The $18.8 Billion Pipeline Could Be Just The Beginning
·Sep 09, 2025
Mobix Labs Goes Hostile? What The Peraso Deal Could Mean For This Aerospace-Tech Challenger
·Sep 09, 2025Breaking News
Impact Biomedical, Inc. Announces U.S. Patent Allowance of Laetose™ Technology Entitled “Low Glycemic Sugar Composition.”
Impact Biomedical Inc. (IBIO), in which DSS Inc.(NYSE American: DSS) has a significant investment, is thrilled to announce a milestone in its innovative Laetose™ technology platform. The U.S. Patent and Trademark Office (USPTO) has issued U.S. patent # 11,898,184, entitled “Low Glycemic Sugar Composition” developed within this platform.
Bruush Oral Care Inc. and Arrive Technology Inc. Announce Agreement and Plan of Merger
scdadmin·Dec 15, 2023
Deep Dive & Research
Healthcare & Biotech
Phreesia’s $160 Million AccessOne Acquisition: Will This Deal Redefine Healthcare Payments?
Phreesia is charting new territory with its recently announced $160 million all-cash acquisition of AccessOne Parent Holdings, a healthcare financing firm with a receivables portfolio of $450 million.
Y-mAbs’ $412 Million Take-Private Offer From SERB Poised To Upset The Oncology Landscape
Merck’s $10 Billion Bet On Verona: Smart Strategic Pivot Or Costly Diversion From The Keytruda Cliff?
Eli Lilly’s Obesity Pill Could Be a Game-Changer — But Here’s Why Zepbound Already Has a Giant Lead
DexCom’s Bold Type 2 Bet Could Reshape The Glucose Monitoring Market—What It Means for Investors!
Eli Lilly’s $1.3 Billion Gene Editing Bet: What the Verve Deal Signals for the Future of Heart Disease!
Join our newsletter
Read and share new perspectives on just about any topic. Everyone’s welcome.- 01Create a free account
- 02Write your story
Tech & Energy
CrowdStrike Sees AI as Both Threat and Opportunity in Cybersecurity Market
CrowdStrike (NASDAQ: CRWD), a leading cybersecurity firm, is positioning itself at the forefront of the industry as artificial intelligence reshapes both threats and defenses.
